Webinar: Combined immunohistochemistry and RNA in situ hybridization to elucidate tumor molecular heterogeneity in prostate cancer
In this webinar:
- How RNA in situ hybridization (ISH) analysis of prostate cancer can unravel the molecular heterogeneity of the tumor.
- How RNA in situ hybridization (ISH) identifies molecular subsets and detect key fusions and mutations of the RNA.
- A comparison of IHC and ISH technology and the combination of dual color IHC and dual color ISH can be used to enhance simultaneous evaluation of DNA, RNA and protein, revealing the molecular profile of prostate cancer.
